ICCM IceCure Medical Ltd.

$0.77 -12.50%

Data as of Nov 3, 2026 close

Healthcare · Surgical & Medical Instruments & Apparatus

IceCure Medical Ltd. (ICCM) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $2 million. Shares last traded at $0.77, 96.4% below their 52-week high. Over the past year the stock is down 96.2%. Net profit margin is -445.6%, below the peer median of -6.3%. Revenue grew 2.7% year over year.

Market Cap

$2M

Shares Out

2.6M

EPS (TTM)

$0.24

P/E (TTM)*

—

P/S Ratio

0.60

P/B Ratio

0.22

Dividend / Share

—

Dividend Yield

—

52-Week High

$21.28

52-Week Low

$0.76

Volume (venue)

2,470

Avg Vol (3m, venue)

3,290.746

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

-26.67%

-51.27%

-75.48%

-90.71%

YTD

-95.50%

-96.23%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. ICCM split history →

Technicals

RSI (14)

17.10

SMA (50)

$1.63

SMA (200)

$7.41

Price vs SMA50

-52.70%

Price vs SMA200

-89.61%

ATR (14)

$0.10

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$3M

Net Income

-$15M

Gross Margin

36.3%

Operating Margin

-446.7%

Net Margin

-445.6%

Return on Equity

-166.4%

Return on Assets

-108.4%

Current Ratio

2.61

Debt / Equity

0.00

Revenue Growth (YoY)

+2.7%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2025-12-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Surgical & Medical Instruments & Apparatus peers

ICCM vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Data as of Nov 3, 2026 close

P/S vs peers

0.60 / 3.03 med

-80% discount

Net margin vs peers

-445.6% / -6.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	32.63	4.50	13.8%	+1.18%
MMM	3M	$91.5B	25.87	3.62	14.0%	-0.77%
BSX	Boston Scientific	$63.1B	18.05	2.99	16.6%	-1.87%
BDX	Becton Dickinson	$54.0B	57.37	2.59	4.5%	-0.20%
RMD	ResMed	$31.9B	20.05	5.57	27.8%	-2.48%
DXCM	DexCom	$30.9B	31.23	6.06	19.4%	-2.11%
MDLN	Medline Inc.	$29.9B	—	1.05	—	+1.40%
WST	West Pharmaceutical Services	$28.4B	44.39	8.35	18.8%	-0.17%
SOLV	Solventum	$14.4B	10.06	1.74	17.3%	+0.02%
GKOS	Glaukos Corp	$13.8B	—	19.98	-24.6%	-2.42%
BAX	Baxter International	$13.2B	—	1.14	-6.2%	+5.27%
PEN	Penumbra Inc	$12.6B	80.34	8.99	11.2%	-0.41%
PODD	Insulet Corporation	$10.7B	28.62	3.52	12.3%	+0.78%
GMED	Globus Medical Inc	$10.7B	19.95	3.40	17.0%	+0.14%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.